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Summary
Cell diversity and organization in the neural tube depend on
the integration of extrinsic signals acting along orthogonal
axes. These are believed to specify distinct cellular identities
by triggering all-or-none changes in expression of combina-
tions of transcription factors [1]. Under the influence of a
common dorsoventral signal, sonic hedgehog, and distinct
anterior-posterior (A-P) inductive signals [2, 3], two topo-
graphically related progenitor pools that share a common
transcriptional code produce serotonergic and V3 neurons
in the hindbrain and spinal cord, respectively [4–7]. These
neurons have different physiological properties, functions,
and connectivity [8, 9]. Serotonergic involvement in neuro-
psychiatric diseases has prompted greater characterization
of their postmitotic repertoire of fate determinants, which
include Gata2, Lmx1b, and Pet1 [10], whereas V3 neurons
express Sim1 [4]. How distinct serotonergic and V3 neuronal
identities emerge from progenitors that share a common
transcriptional code is not understood. Here, we show that
changes in retinoid activity in these two progenitor pools
determine their fates. Retinoids, via Notch signaling, control
the expression level in progenitors of the transcription factor
Ascl1, which selects serotonergic and V3 neuronal identities
in a dose-dependent manner. Therefore, quantitative differ-
ences in the expression of a single component of a transcrip-
tional code can select distinct cell fates.Results
Through the inductive effects of signaling molecules such as
sonic hedgehog [4] and fibroblast growth factors [3], hindbrain
serotonergic (5HT) progenitors acquire a Foxa2+Nkx2.2+*Correspondence: jjacob@nimr.mrc.ac.uk (J.J.), jbrisco@nimr.mrc.ac.uk
(J.B.)Ascl1+ transcriptional code. Topographically related V3 neural
progenitors in the spinal cord express the same three factors
(see Figure S1A available online). All three factors have been
shown to be necessary for the generation of 5HT neurons,
and Nkx2.2 and Ascl1 are critical for V3 neurogenesis [4, 5,
11, 12]. Consistent with its expression in spinal cord p3
progenitors, Foxa2 is also required for the generation of V3
neurons (Figures S1B, S1D, andS1E) [13]. This raises the ques-
tion of how hindbrain and spinal p3 progenitors, designated p3
[5HT] and p3[V3], respectively, generate different cell types.
Retinoids Regulate p3 Progenitor Identity
We analyzed b-gal expression in the hindbrain and spinal cord
ofRARE-LacZ transgenic reportermice [14]. The hindbrain has
a segmental organization and is composed of eight compart-
ments termed rhombomeres [15]. b-gal immunostaining re-
vealed low or absent RA signaling in p3[5HT] progenitors at
multiple rhombomeric levels, but high levels of activity in p3
[V3] cells (Figure S2A). This is consistent with other assays of
retinoid signaling in amniotes (for example, see [16, 17]) and
suggested that retinoid signaling could be involved in p3
progenitor fate determination. To test this, we took advantage
of a constitutively active retinoid receptor a derivative,
VP16RAR, which has previously been shown to activate reti-
noic acid receptor target genes independently of RA [18].
Forced expression of VP16RAR by in ovo electroporation
reduced 5HT neuronal differentiation by 40%–50% throughout
the A-P extent of the hindbrain (Figures 1A–1C). Concomi-
tantly, occasional ectopic V3 neurons, marked by expression
of the postmitotically expressed transcription factor Sim1,
were produced in the caudal hindbrain (data not shown) [4].
Conversely, blockade of retinoid signaling in p3[V3] progeni-
tors, either by misexpression of Cyp26B1, a member of the
cytochrome P450 class of enzymes that degrades retinoic
acid, or RAR403, a dominant negative version of the human
RA receptor a [19], resulted in ectopic 5HT neuronal generation
(Figure 1D). These neurons expressed the postmitotic seroto-
nergic determinants Gata2 [20] and Lmx1b [21, 22], but not
Pet1 [23], and they also expressed the terminal differentiation
marker Tph2 [24] (Figure 1E). Therefore, ectopic spinal 5HT
neurons share the same differentiation pathway as hindbrain
5HT neurons, of which approximately one-third do not depend
on Pet1 for their generation [25, 26].
The ventral restriction of ectopic spinal 5HT neurons sug-
gested their derivation from presumptive p3[V3] progenitors,
and blockade of Nkx2.2 or Foxa2 activity using a dominant
interfering derivative of Nkx2.2 (Nkx2.2-VP16) [27] or Foxa2
(FkhA2-EnR) [5], respectively, prevented RAR403 induction of
ectopic 5HT neurons (Figure S2B). Consistent with these
data, forced expression of Foxa2, Nkx2.2, and RAR403 in the
dorsal neural tube led to extensive ectopic generation of 5HT
neurons, whereas the omission of RAR403 led to a failure to
induce ectopic 5HT neurons (Figure 1F). This result also sug-
gested that the small number of ectopic 5HT neurons gener-
ated by p3[V3] in ovo electroporation with RAR403 is likely to
be a consequence of the restricted overlap of endogenous
Foxa2 and Nkx2.2 expression and mosaic misexpression of
RAR403. Furthermore, as quantified below, at brachial level
Figure 1. Retinoid Signaling Determines p3
Progenitor Fate
(A) Upregulation of RA signaling in hindbrain
p3[5HT] progenitors by misexpression of
VP16RAR-IRES GFP reduces Pet1 expression.
Scale bar represents 25 mm.
(B and C) Effect of VP16RAR misexpression on
Pet1+ neurons in the rostral (B) or caudal (C) hind-
brain at E5. *p = 0.025 (B, blue bar), *p = 0.026
(B, red bar), *p = 8.11 3 1026 (C, black bar)
(unpaired Student’s t tests). Error bars represent
SD in all graphs. r, rhombomere.
(D) Forced expression of Cyp26B1 or RAR403 in
p3[V3] generates ectopic 5HT neurons (arrow-
heads) by E5. Scale bar represents 14 mm.
(E) Ectopic spinal 5HT neurons express the indi-
cated markers (arrowheads), and Sim1 expres-
sion is reduced. Asterisk marks the floor plate.
Scale bar represents 16 mm.
(F) Nkx2.2 and Foxa2 misexpression only induce
ectopic spinal 5HT neurons when RA signaling
is blocked by RAR403. –, control side; +, electro-
porated side. See also Figure S2.
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413the p3 domain normally only generates relatively small
numbers of V3 neurons, suggesting that low neurogenic
potential might further limit ectopic 5HT neurogenesis.
V3 neuronal differentiation was suppressed by 60% upon
RAR403misexpression (V3 neurons in control = 10.7 [mean]6
4.1 [SD]; V3 neurons following RAR403misexpression = 4.7 6
2.2; p = 7.183 1029, unpaired Student’s t test) (Figure 1E). This
was not due to cell death or to a fate transformation to other
ventral neuronal subtypes (Figure S2C). Furthermore, ectopic
visceral motor (VM) neurons that precede the generation of
5HT neurons in the hindbrain from p3 progenitors [6] (Fig-
ure S1A) were not detected (Figure S2C). Altogether, these
data indicate that high-level, versus low-level or absent,
retinoid signaling in p3[V3] and p3[5HT], respectively, deter-
mines the corresponding neuronal identities.
Retinoids Regulate Ascl1 Expression in p3 Progenitors via
the Notch Pathway
The profile of RA signaling in the ventral neural tube corre-
lates with the longitudinal expression of Ascl1 in p3
progenitors (Figures S1C and S2A). The significance of thisobservation lies in the critical subtype-
specification function of Ascl1 in
p3[5HT] and p3[V3] progenitors, which
is separable from its neurogenic prop-
erties [11, 12]. In the p3[5HT] domain
where RA signaling is weak or absent,
the expression level of chick Ascl1 ap-
peared markedly higher than in the p3
[V3] domain where RA signaling is
strong (Figure S1C). This observation
prompted closer scrutiny of the expres-
sion of Ascl1 in p3 progenitors in the
spinal cord and hindbrain (Figures 2A
and 2B). Indeed, the mean level of
Ascl1 expression was consistently
greater in p3[5HT] than in p3[V3] pro-
genitors between E9.5 and E11.5.
Moreover, Ascl1 expression level was
enhanced in hindbrain p3 progenitorsafter E9.5, corresponding to the time 5HT neurogenesis
commences [5].
The Notch pathway is known to inhibit proneural gene
expression, and, consistent with this regulatory relationship,
in chick p3 progenitors the Hes family of Notch target genes
showed reciprocal patterns of expression to Ascl1 (Figures
S2D and S2E). Moreover, the Notch pathway lies downstream
of retinoid signaling. Misexpression of RAR403 in the p3[V3]
domain led to the downregulation of the Notch pathway by
E4 (Figure 2C). Conversely, forced expression of VP16RAR in
the hindbrain p3[5HT] domain upregulated Notch activity (Fig-
ure 2D). Retinoid regulation of the Notch pathway suggested
Notch signaling might serve to link the A-P pattern of retinoid
activity and Ascl1 expression in p3 progenitors.
To test whether the expression level of Ascl1 in p3[5HT] and
p3[V3] is regulated by retinoid signaling, we analyzed Ascl1
expression in chick p3 progenitors following cell-autonomous
blockade or activation of RA signaling. RAR403 markedly up-
regulated Ascl1 expression in the p3[V3] domain by E5 24 hr
after the downregulation of the Notch pathway (control
p3[V3] expression = 126 [mean] 6 19.3 [SD] [arbitrary units];
Figure 2. Ascl1 Expression Level in p3 Progenitors Is Negatively Correlated with Notch Activity, which in Turn Is Regulated by Retinoids
(A andB) Ascl1 expression inmouse Nkx2.2+ p3 progenitors (A), with quantification (mean6SD) shown in (B). Scale bar represents 9 mm. a.u., arbitrary units.
n = 3 sections from each of three embryos per developmental stage.
(C) Spinal RAR403 misexpression, marked by anti-GFP immunofluorescence, downregulates Hes gene expression (bracketed).
(D) Misexpression of VP16RAR upregulates hindbrain p3 Hes gene expression.
(E) Misexpression of RAR403 in p3[V3] progenitors upregulates Ascl1 expression (arrowhead, inset) at E5, and this is prevented by cAscl1-shRNA. Inset
shows a high-power image of the boxed region. Scale bar represents 18 mm.
(F) VP16RAR misexpression attenuates Ascl1 expression (arrowhead) in p3[5HT] progenitors. Scale bar represents 18 mm.
(G) Increased Ascl1 expression in brachial Nkx2.2+ p3[V3] cells (white brackets) of RbpjCKO mouse embryos is similar to Ascl1 expression in WT p3[5HT]
cells. Scale bar represents 14 mm.
(H) Quantification of Ascl1 expression in presumptive p3[V3] cells misexpressing RAR403 or RAR403 and cAscl1-shRNA.
(I) Misexpression of Hes1-IRES GFP in caudal hindbrain p3[5HT] reduces Ascl1 expression. Scale bar represents 18 mm. See also Figure S1.
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414RAR403 p3[V3] expression = 221.6 6 7.8; control p3[5HT]
expression = 223.1 6 26.3). (Figures 2E and 2H; Figure S2F).
Moreover, the upregulation of Ascl1 could be prevented by
the comisexpression of a short hairpin RNA against chick
Ascl1 (cAscl1-shRNA) (control p3[V3] expression = 110.9
[mean] 6 19.4 [SD]; RAR403 + cAscl1-shRNA p3[V3] expres-
sion = 107.1 6 11.2; control p3[5HT] expression = 208.4 6
27.5) (Figures 2E and 2H). By contrast, misexpression of
VP16RAR in p3[5HT] progenitors downregulated Ascl1 by E4
1 day after the upregulation of the Notch pathway in these
progenitors (control p3[5HT] expression = 193.1 [mean] 6
27.1 [SD]; VP16RAR p3[5HT] expression = 94.46 16.9; control
p3[V3] expression = 105.16 16.9) (Figure 2F). In neither condi-
tion were there detectable changes in expression of the other
proneural genes, Neurog1 and Neurog2, or of other ventral
progenitor markers or sonic hedgehog. Moreover, there was
no increase in cell death (Figures S2F–S2H).
To determine whether Notch signaling regulates Ascl1
expression in p3 progenitors, we conditionally deleted recom-
bination signal binding protein for immunoglobulin kappa j
region (Rbpj), an obligate component of the Notch signaling
pathway [28], using Olig2-cre [29]. At E10.5, mice lacking
Rbpj (RbpjCKO) expressed higher levels of Ascl1 in the spinal
cord p3 domain, compared to either mice that have only
one conditional allele or mice that lacked Cre (WT p3[V3]expression: 50.5 [mean Ascl1 expression] 6 28.0 [SD];
Rbpjflox/+ p3[V3] expression: 49.3 6 29.0; RbpjCKO p3[V3]
expression: 78.1 6 50.4; WT p3[5HT] expression: 90.3 6
56.8) (Figure 2G). Conversely, misexpression of Hes1, an
effector of Notch signaling, in the caudal hindbrain of the chick
lowered the expression of Ascl1 in p3[5HT] progenitors to
levels comparable to the expression of Ascl1 in spinal cord
p3 progenitors (control p3[5HT] = 221.9 [mean] 6 20.9 [SD];
Hes1 electroporation p3[5HT] = 123.4 6 8.7; control p3[V3] =
119.8 6 22.1) (Figure 2I). The expression of Foxa2 and
Nkx2.2 were unaffected (Figure S2I). Together, these gain-
and loss-of-function data suggested that differential expres-
sion of Ascl1 in the two p3 progenitor pools is determined by
retinoid signaling acting via the Notch pathway. Furthermore,
our findings raised the possibility that differences in the
expression level of Ascl1 might determine p3 progenitor fate.
Ascl1 Expression Level Discriminates p3[V3] from p3[5HT]
Progenitors
We exploited the regulatory relationship between Notch
signaling and proneural gene expression to test the effect of
boosting Ascl1 expression in the spinal cord on p3 pro-
genitor fate. Strikingly, although 5HT neurons are normally
never found in this region of the neural tube, ectopic spinal
5HT+GFP+ neuronal cell bodies were observed in the cervical
Figure 3. Altering Ascl1 Expression Level in p3
Progenitors Produces Corresponding Changes
in p3 Progenitor Identity
(A and B) Ectopic 5HT+GFP+ neurons (yellow
cells, arrowheads) in the cervical cord of Rbpj
mutants (A) and 5HT+ cells in the brachial cord
of Hes5 mutants (B). Insets show high-power
images of 5HT+GFP+ neurons in boxed regions.
Scale bar represents 25 mm in (A) and 13 mm in (B).
(C) Forced Ascl1 expression in cervicobrachial
p3[V3] cells induces ectopic 5HT neurons
(arrows) and reduces V3 differentiation. Cell
death, assayed by activated Caspase3 expres-
sion, is not detected in the ventral spinal cord.
Ascl1, but not Neurog2, substitutes for RAR403
in combined electroporation with Foxa2 and
Nkx2.2 to induce ectopic spinal 5HT neurons.
Scale bar represents 13 mm.
(D) Ectopic Lmx1b andGata2 expression (arrows)
upon combined Foxa2, Nkx2.2, and Ascl1 elec-
troporation at brachial level. Scale bar represents
14 mm.
(E) Hes1-IRES GFP misexpression in caudal
p3[5HT] cells reduces 5HT neuronal differentia-
tion marked by Lmx1b (circled) and Pet1 and
induces ectopic V3 neurons (arrowheads).
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415cords of nine out of nineRbpj conditional null mice and two out
of five Cre/+; Rbpjflox/+ mice (Figure 3A). Moreover, analysis of
embryos lacking Hairy and Enhancer-of-Split (Hes) family
member Hes5, which is a target of Notch signaling broadly ex-
pressed in the spinal cord [30] (Figure 3B), revealed ectopic
5HT neurons in the ventral spinal cord at forelimb levels in
three out of four Hes5+/2 embryos and four out of four Hes5
null embryos. These neurons were more abundant than in
Rbpj mutants: the later deletion of Rbpj in neural cells by
Olig2-cre (wE9.5) might explain the smaller number of 5HT
neurons.
To further explore the role of Ascl1 expression level in regu-
lating p3 progenitor fate, we first increased Ascl1 levels in the
p3[V3] domain by direct overexpression in ovo (Figure 3C).
Boosting the level of Ascl1 in the p3[V3] domain was sufficient
to generate ectopic 5HT neurons cell autonomously and
suppress V3 neuronal differentiation (the number of Sim1+
cells on the electroporated side was 1.59 [mean] 6 1.6 [SD],
and on the control side there were 8.12 6 2.3, p = 2.80 3
10210; n = 18 sections from five embryos), indicating that upre-
gulation of Ascl1 reprograms the p3[V3] domain to a p3[5HT]
identity. Moreover, there was no evidence that cell death, as
revealed by activated Caspase3 immunostaining, couldaccount for the reduced number of V3
neurons (Figure 3C). Next, we misex-
pressed the three p3-defining transcrip-
tion factors,Nkx2.2, Foxa2, andAscl1, in
the dorsal spinal cord. The widespread
and cell-autonomous generation of
ectopic 5HT neurons that resulted
shows that Ascl1 can substitute for
RAR403 and supports the view that
high-level Ascl1 expression is sufficient
to select a p3[5HT] identity over a p3
[V3] identity (Figure 3C). Ectopic 5HT
neurons expressed postmitotic markers
of hindbrain 5HT neurons Lmx1b and
Gata2, but not Pet1 (Figure 3D anddata not shown), suggesting that the differentiation of these
neurons largely recapitulates the serotonergic differentiation
pathway. Importantly, neither overexpression of Foxa2 and
Nkx2.2 alone nor replacement of Ascl1 by another bHLH
gene, Neurog2, led to ectopic 5HT neuronal generation
(Figures 1F and 3C). Therefore, increasing the expression of
Ascl1 converts p3[V3] to a p3[5HT] identity.
We then asked whether reducing the expression of Ascl1 in
presumptive p3[5HT] progenitors would cause a reciprocal
switch to a p3[V3] identity. Following Hes1 in ovo electropora-
tion into presumptive p3[5HT] progenitors, significant reduc-
tions in 5HT neuronal differentiation were observed, using
Lmx1b and Pet1 as markers (control side 5HT neurons = 8.2
[mean] 6 2.8 [SD]; Hes1-electroporated side = 2.5 6 2.1, p =
8.2 3 1028), and small numbers of Sim1-expressing ectopic
V3 neurons were consistently detected in the caudal hindbrain
(Figure 3E). This is consistent with the low neurogenic potential
of the caudal hindbrain p3[5HT] domain. The block in genera-
tion of ectopic V3 neurons by comisexpression ofNkx2.2-VP16
confirmed the derivation of these Hes1-induced ectopic V3
neurons from the presumptive p3[5HT] domain (Figure S3A).
To further test the idea that Ascl1 expression level is important
for p3[5HT] identity, we measured the expression of Ascl1 in
Figure 4. Knockdown of Chick Ascl1 Alters p3
Progenitor Identity
(A) Misexpression of cAscl1-shRNA IRES RFP
decreases Ascl1 expression in hindbrain p3
progenitors (bracket) and reduces Pet1 (arrow-
head) and Lmx1b expression (short arrows).
Dotted white line demarcates Lmx1b expression
corresponding to the floor plate. RFP expression
on the control side is confined to decussating
axons. Scale bar represents 18 mm.
(B) Coelectroporation of cAscl1-shRNA and
rAscl1 rescues Pet1 expression (arrowhead).
(C) cAscl1-shRNA restores Sim1+ V3 neurons
(arrowhead) and blocks ectopic spinal 5HT
expression induced by RAR403. Scale bar repre-
sents 13 mm.
(D and E) Quantification of Pet1+ neurons in the
caudal hindbrain at E5 following forced expres-
sion of cAscl1-shRNA (D) or cAscl1-shRNA and
rAscl1 (E). Red asterisk, p = 0.028; blue asterisk,
p = 0.002. See also Figure S3.
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416Ascl1 heterozygotemice, in which 5HT neuronal differentiation
is intact [11]. No significant change in Ascl1 expression was
detected (WT p3[5HT] expression: 151.1 [mean] 6 53.2 [SD];
Ascl1+/2 p3[5HT] expression: 149.3 6 39.7), which implies
that allele number is not the main determinant of the level of
Ascl1 expression (Figure S3B). Together, these data support
the case for the critical role of Ascl1 expression level in the
selection of 5HT over V3 neuronal fate.
Finally, to test directly whether the level of Ascl1 determines
p3 progenitor fate, we used cAscl1-shRNA. Forced expression
of cAscl1-shRNA in the ventral region of the caudal hindbrain
reduced the expression of Ascl1 in hindbrain p3 progenitors
(control p3[5HT] expression: 213.6 [mean] 6 22.8 [SD];
cAscl1-shRNA p3[5HT] expression: 123.9 6 13.3; control
p3[V3] expression: 119.5 6 19.5), and this was accompanied
by aw40% reduction in 5HT neuronal differentiation (Figures
4A and 4D). Consistent with the retinoid and Notch pathway
gain-of-function experiments in the caudal hindbrain in ovo,
occasional ectopic V3 neurons were also detected (Fig-
ure S3C). We then attempted to rescue these neural patterning
defects by comisexpression of rat Ascl1 (rAscl1), which is
predicted to be resistant to this shRNA (Figure 4B). rAscl1
restored serotonergic neurogenesis and prevented the
ectopic generation of any V3 neurons by cAscl1-shRNA (Fig-
ures 4B and 4E; Figure S3D). Transfection of a scrambled
version of the chick Ascl1 shRNA (cAscl1-shRNA-SCR) did
not alter the expression of Ascl1 in p3[5HT] progenitors
(control p3[5HT] expression = 185.9 [mean] 6 30.1 [SD];
cAscl1-shRNA-SCR p3[5HT] expression = 176.0 6 38.5), nor
did it alter 5HT neurogenesis or induce any ectopic V3 neurons
(Figures S3E and S3F). Furthermore, when the increased
expression of Ascl1 in p3[V3] progenitors elicited by RAR403was prevented by comisexpression of
cAscl1-shRNA (Figure 2E), V3 neuronal
differentiation was rescued (V3 neurons
in control = 11 [mean] 6 4.6 [SD]; V3
neurons following RAR403 + cAscl1-
shRNA misexpression = 10.8 6 5.1;
p = 0.92, not significant), and ectopic
5HT neuronal generation was blocked
(Figure 4C). Taken together, these data
indicate that Ascl1 recapitulates the
effect of retinoids on p3 progenitoridentity and that retinoids regulate the neuronal fates of p3
progenitors in an Ascl1-dependent manner.
Discussion
We have shown how different profiles of retinoid signaling in
p3 progenitors that share a common transcriptional code
generate distinct neuronal identities at spinal cord and hind-
brain levels. Binary differences in retinoid activity result in
graded shifts in expression of a pivotal transcription factor,
Ascl1, which is critical for the selection of alternate progenitor
identities. This mechanism of progenitor fate specification is
distinct from the conventional combinatorial model, because
allocation to V3 or 5HT neuronal identity is determined not
by qualitative but by quantitative differences in the transcrip-
tional code [1]. Moreover, this model does not exclude the
possibility that other, as yet uncharacterized, intrinsic determi-
nants function in the same pathway as Ascl1 and could
discriminate p3[5HT] from p3[V3].
In invertebrates, graded activity of transcription factors has
been shown to control differential gene expression and
thereby diversify cell fates [31]. By contrast in vertebrates, in
general, transcription factor gradients appear to refine neural
identity rather than instruct distinct cell identities in a dose-
dependent manner [32–36]. Consistent with their closely
similar genetic identities, the manipulations of retinoid sig-
naling and Ascl1 expression demonstrate that spinal p3
progenitors possess a cryptic bipotency. The induction of
ectopic V3 neurons in the hindbrain is less robust, which
implies that hindbrain p3 progenitors are not fully interconvert-
ible by graded Ascl1 expression alone. Nevertheless, it is clear
that Ascl1 expression must be tightly regulated to regionally
Graded Ascl1 Expression and Control of Neural Fate
417constrain 5HT neurogenesis. Importantly, failure to appropri-
ately regulate the number of 5HT neurons is associated with
neuropsychiatric disease states, for example Smith-Lemli-
Opitz syndrome, in which hypermorphic serotonergic differen-
tiation occurs [37].
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